Evidence map›Paper›PMID 28903800›Full record

ArticleEpidemiology and infection2017

Predicting treatment failure, death and drug resistance using a computed risk score among newly diagnosed TB patients in Tamaulipas, Mexico.

B E Abdelbary, M Garcia-Viveros, H Ramirez-Oropesa, M H Rahbar, B I Restrepo

Open access · bronzeAbstract read
In one paragraph

Article in Epidemiology and infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Interferon gamma release assays for detection of latent Mycobacterium tuberculosis in older Hispanic people.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

B E AbdelbaryDepartment of Epidemiology,Human Genetics and Environmental Sciences,School of Public Health in Brownsville,University of Texas Health Science Centre at Houston,Brownsville,Texas,USA.
M Garcia-ViverosSecretaria de Salud de Tamaulipas and Ciudad Victoria,Ciudad Victoria,Mexico.
H Ramirez-OropesaSecretaria de Salud de Tamaulipas and Ciudad Victoria,Ciudad Victoria,Mexico.
M H RahbarDepartment of Epidemiology,Human Genetics and Environmental Sciences,School of Public Health at Houston and Division of Clinical and Translational Sciences,Department of Internal Medicine,McGovern Medical School,and The Centre for Clinical and Translational Sciences,University of Texas Health Science Centre at Houston,Texas,USA.
B I RestrepoDepartment of Epidemiology,Human Genetics and Environmental Sciences,School of Public Health in Brownsville,University of Texas Health Science Centre at Houston,Brownsville,Texas,USA.
Secretaria de Salud · MXUniversidad Internacional de América · MX

Funding

U OF TEXAS HLTH SCI CTR HOUSTON CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCESUL1RR024148 · NCRR · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2006 to 2010
$27.9M
Center for Clinical and Translational Sciences (CCTS)UL1TR000371 · NCATS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI MCPHERSON, DAVID D · 2012 to 2016
$13.4M
NCATS NIH HHS UL1 TR000371NCRR NIH HHS UL1 RR024148
6 · The paper itself

Abstract

The purpose of this study was to develop a method for identifying newly diagnosed tuberculosis (TB) patients at risk for TB adverse events in Tamaulipas, Mexico. Surveillance data between 2006 and 2013 (8431 subjects) was used to develop risk scores based on predictive modelling. The final models revealed that TB patients failing their treatment regimen were more likely to have at most a primary school education, multi-drug resistance (MDR)-TB, and few to moderate bacilli on acid-fast bacilli smear. TB patients who died were more likely to be older males with MDR-TB, HIV, malnutrition, and reporting excessive alcohol use. Modified risk scores were developed with strong predictability for treatment failure and death (c-statistic 0·65 and 0·70, respectively), and moderate predictability for drug resistance (c-statistic 0·57). Among TB patients with diabetes, risk scores showed moderate predictability for death (c-statistic 0·68). Our findings suggest that in the clinical setting, the use of our risk scores for TB treatment failure or death will help identify these individuals for tailored management to prevent these adverse events. In contrast, the available variables in the TB surveillance dataset are not robust predictors of drug resistance, indicating the need for prompt testing at time of diagnosis.

Indexed as

Drug Resistance, Multiple, BacterialAdultAgedAntitubercular AgentsFemaleHumansMaleMexicoMiddle AgedMycobacteriumPublic HealthTreatment FailureTuberculosisTuberculosis, Multidrug-ResistantYoung AdultAntitubercular AgentsPublic healthrisk assessmenttreatment outcomes in TBtuberculosis (TB)

Identifiers

PMID28903800
PMCPMC9152743
OpenAlexW2754211652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.